ANTITUMOUR COMBINATION COMPRISING OMBRABULIN AND CETUXIMAB, ASSOCIATED WITH RADIOTHERAPY

摘要

The invention relates to an antitumour pharmaceutical combination comprising ombrabulin or AVE8062, which may be in the form of a base or in the form of a pharmaceutically acceptable salt, and cisplatin, for use thereof as an antitumour agent intended for patients who are also treated with radiotherapy, in particular suffering from cancers and even more particularly suffering from solid tumours.